Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Harvard Apparatus Regenerative Technology, Inc.HRGN · Entity 7501 | Director | June 27, 2025 | July 01, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Harvard Apparatus Regenerative Technology, Inc.
Report date June 27, 2025 · Filed July 01, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.60 · Expires 2035-06-27 | Direct | 18,590 |
Reported balance
After 2025-06-27 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-06-27 · Grant · Acquired 18,590 · Balance 18,590 F1: This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 27, 2025, December 27, 2025, March 27, 2026 and June 27, 2026. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.60 · Expires 2035-06-27 | Direct | 15,227 |
Reported balance
After 2025-06-27 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-06-27 · Grant · Acquired 15,227 · Balance 15,227 F2: This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2025, September 30, 2025 and December 31, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 27, 2025, December 27, 2025, March 27, 2026 and June 27, 2026.
F2: This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2025, September 30, 2025 and December 31, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 27, 2025 Filed Jul 1, 2025 18:03 UTC | Harvard Apparatus Regenerative Technology, Inc. HRGN · Entity 7501 | GrantStock Option (right to buy) · Derivative | 15,227 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001437749-25-021710 · rdgdoc.xml · derivative · entry 2 Zhang Mao · CIK 0002036199 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,227 Underlying: Common Stock, par value $0.01 per share · 15,227 shares Expires 2035-06-27 F2 · derivative.exercise_date: This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2025, September 30, 2025 and December 31, 2025. Read SEC document |
| June 27, 2025 Filed Jul 1, 2025 18:03 UTC | Harvard Apparatus Regenerative Technology, Inc. HRGN · Entity 7501 | GrantStock Option (right to buy) · Derivative | 18,590 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001437749-25-021710 · rdgdoc.xml · derivative · entry 1 Zhang Mao · CIK 0002036199 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,590 Underlying: Common Stock, par value $0.01 per share · 18,590 shares Expires 2035-06-27 F1 · derivative.exercise_date: This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 27, 2025, December 27, 2025, March 27, 2026 and June 27, 2026. Read SEC document |
| September 03, 2024 Filed Sep 26, 2024 13:33 UTC | Harvard Apparatus Regenerative Technology, Inc. HRGN · Entity 7501 | GrantStock Option (right to buy) · Derivative | 7,198 | $0.00 Strike: $4.12 | $0.00 |
DisclosureSEC source: 0001493152-24-038228 · ownership.xml · derivative · entry 1 Zhang Mao · CIK 0002036199 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,198 Underlying: Common Stock, par value $0.01 per share · 7,198 shares Expires 2034-09-03 F1 · derivative.exercise_date: This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on December 3, 2024, March 3, 2025, June 3, 2025 and September 3, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.